AnaptysBio Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 151.39, 207.68, 285.12, 334.68, 448.33 ], "ebit_estimate": [ 4.4, 34.6, 139.26, 136.98, 220.8 ], "ebitda_estimate": [ 114.6, 214.6, 282.4, 284.5, 343.5 ], "net_income_estimate": [ -88.56, -14.97, 10.3, 26.68, 92.5 ], "per_share_eps_estimate": [ -1.57, 1.5, 3.69, 4.76, 5.79 ], "eps_nri_estimate": [ -1.32, 0.97, 2.01, 2.93, 4.25 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.6, 8.51, 6.63, null, null ], "pretax_income_estimate": [ -44.44, -10.81, 120.64, 131.36, 200.67 ], "operating_cash_flow_per_share_estimate": [ 2.81, 5.84, 0.28, null, null ], "roa_estimate": [ 7.8, 35.2, null, -21.9, null ], "roe_estimate": [ 69.58, 98.51, null, -669.6, null ], "gross_margin_estimate": [ 100, 100, 79, 98.5, 97.33 ], "operating_cash_flow_estimate": [ 80.62, 167.56, 8.03, null, null ], "pettm_estimate": [ 0, 44.34, 17.99, 13.98, 11.48 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 62.32, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 91.46, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -6.83, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 30.66, 38.74, 53.14, 11.13, 13.67, 48.63, 116.7 ], "ebit_estimate": [ 0.78, 6.43, 15.53, -56.29, -59.36, 12.77, 59.23 ], "ebitda_estimate": [ 10.35, 29.1, 43.9, null, null, null, null ], "net_income_estimate": [ -23.09, -17.47, -20, -2.15, 2.9, 72.96, 114.44 ], "per_share_eps_estimate": [ -0.17, 0.03, 0.37, 0.53, 0.69, 1.9, 3.28 ], "eps_nri_estimate": [ -0.11, 0.07, 0.27, 0.53, 0.69, 1.9, 3.28 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ -4.5, -5.69, -6.32, null, null, null, null ], "pretax_income_estimate": [ -13.61, -7.84, 0.43, -2.15, 2.9, 72.96, 114.44 ], "operating_cash_flow_per_share_estimate": [ -1.11, -0.97, -0.36, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null ], "operating_cash_flow_estimate": [ -31.85, -27.83, -10.33, null, null, null, null ], "pettm_estimate": [ 88.03, 41.1, 19.05, 10.39, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 62.32, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 91.46, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -6.83, "future_operating_cash_flow_per_share_estimate_growth": null }